| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Vascular Biology Center,
2 Department of Pharmacology and
Toxicology, and 4 Department
of Pediatrics,
Angiotensin II (ANG II) exerts its effects on vascular smooth muscle cells through G protein-coupled AT1 receptors. ANG II stimulation activates the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway by inducing tyrosine phosphorylation, activation, and association of JAK2 with the receptor. Association appears to be required for JAK2 phosphorylation. In the present study, electroporation experiments with neutralizing anti-Src homology phosphatase-1 (SHP-1) and anti-SHP-2 antibodies and time course determinations of SHP-1 and SHP-2 activation and complexation with JAK2 suggest that the tyrosine phosphatases, SHP-1 and SHP-2, have opposite roles in ANG II-induced JAK2 phosphorylation. SHP-1 appears responsible for JAK2 dephosphorylation and termination of the ANG II-induced JAK/STAT cascade. SHP-2 appears to have an essential role in JAK2 phosphorylation and initiation of the ANG II-induced JAK/STAT cascade leading to cell proliferation. The motif in the AT1 receptor that is required for association with JAK2 is also required for association with SHP-2. Furthermore, SHP-2 is required for JAK2-receptor association. SHP-2 may thus play a role as an adaptor protein for JAK2 association with the receptor, thereby facilitating JAK2 phosphorylation and activation.
vascular smooth muscle cells; tyrosine phosphatases; adaptor protein
This article has been cited by other articles:
|
|
 |
|
  J. Bregeon, G. Loirand, P. Pacaud, and M. Rolli-Derkinderen Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1062 - C1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kimura and S. Eguchi Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells" Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1059 - C1061. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kurdi and G. W. Booz JAK redux: a second look at the regulation and role of JAKs in the heart Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1545 - H1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. L. Banes-Berceli, P. Ketsawatsomkron, S. Ogbi, B. Patel, D. M. Pollock, and M. B. Marrero Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1291 - H1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Marrero, A. K. Banes-Berceli, D. M. Stern, and D. C. Eaton Role of the JAK/STAT signaling pathway in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F762 - F768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Banes, S. Shaw, J. Jenkins, H. Redd, F. Amiri, D. M. Pollock, and M. B. Marrero Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli Am J Physiol Renal Physiol, April 1, 2004; 286(4): F653 - F659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Seki, N. Hashimoto, Y. Suzuki, S. Mori, K. Amano, and Y. Saito Role of Src Homology 2-Containing Tyrosine Phosphatase 2 on Proliferation of Rat Smooth Muscle Cells Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1081 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Seta, M. Nanamori, J. G. Modrall, R. R. Neubig, and J. Sadoshima AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKs J. Biol. Chem., March 8, 2002; 277(11): 9268 - 9277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brown, Y. Lin, and A. Hassid Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1598 - H1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Amiri, V. J. Venema, X. Wang, H. Ju, R. C. Venema, and M. B. Marrero Hyperglycemia Enhances Angiotensin II-induced Janus-activated Kinase/STAT Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., November 5, 1999; 274(45): 32382 - 32386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liang, V. J. Venema, X. Wang, H. Ju, R. C. Venema, and M. B. Marrero Regulation of Angiotensin II-induced Phosphorylation of STAT3 in Vascular Smooth Muscle Cells J. Biol. Chem., July 9, 1999; 274(28): 19846 - 19851. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
